Mrs. Staci H. Safady, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 295 Buck Rd Ste 107, Holland, PA 18966 Phone: 215-310-5915 |
News Archive
For years, medicine has relied on self-reported race/ethnicity as the basis of an array of decisions, from risk for disease to matching organ donors. Now, a study led by researchers at UC San Francisco has found that when that information matters most - in connecting bone marrow donors to patients - the format of the questions may determine how well the answers actually correspond to their genes.
A first of its kind study has shown a dramatic reduction in medication errors in patients with chronic kidney disease when Kaiser Permanente Colorado researchers teamed with pharmacists to use a computerized system to electronically screen prescriptions for unsafe medication orders.
The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the existing Biomedica assays directed against chronic kidney disease - mineral and bone disorder (CKD-MBD) in a growing collection.
In 1844, multiple myeloma was first treated with a rhubarb pill and an infusion of orange peel. Since then, more than 15 drugs have earned FDA approval to treat multiple myeloma and with so many options, a major question has become what cocktail and sequence is best?
Adults with dementia and delirium may soon have a way to combat their delirium, thanks to a $2.4 million, five-year grant from the National Institutes of Health.
› Verified 9 days ago